SCHEMBL3363598

SCHEMBL3363598

C=CCN(C)CCCCCCOc1ccc(N(C)C(=S)Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LSS P48449 19/20 0.53
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3362796 0.89 LSS (0.66) LSSMEN1KMT2A
SCHEMBL3365198 0.88 LSS (0.57) LSSMEN1KMT2A
SCHEMBL3364936 0.88 LSS (0.49) LSSMEN1KMT2A
SCHEMBL3363725 0.87 LSS (0.55) LSSMEN1KMT2A
SCHEMBL3367307 0.85 LSS (0.49) LSSMEN1KMT2A
SCHEMBL3365253 0.85 LSS (0.57) LSSMEN1KMT2A
SCHEMBL3365080 0.85 LSS (0.48) LSSMEN1KMT2A
SCHEMBL7143601 0.84 LSS (0.62) LSSMEN1KMT2A
SCHEMBL3365279 0.84 LSS (0.63) LSSMEN1KMT2A
SCHEMBL3369265 0.83 LSS (0.47) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303503-B1 ANILINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-01-27 EP disclosed
US-6683201-B2 FOR THERAPY AND PROPHYLAXIS OF HYPERCHOLESTEROLEMIA, HYPERLIPEMIA, ARTERIOSCLEROSIS, VASCULAR DISEASES, MYCOSES, PARASITE INFECTIONS, GALLSTONES, TUMORS AND/OR HYPERPROLIFERATIVE DISORDERS, DIABETES HOFFMANN-LA ROCHE INC. 2004-01-27 US disclosed
EP-1303503-A2 ANILINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002006189-A2 ANILINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 WO disclosed